Hisamitsu Pharmaceutical Co. Ltd
Senior Executive Officer and Head of R&D Division at Hisamitsu Pharmaceutical Co., Inc.
Dr. Terahara leads all R&D activities for all Hisamitsu’s products including development of various cutting edge TDDS technologies such as passive transdermal enhancement formulation and microneedles. He joined Hisamitsu in 1991 and has over 25 years’ experience in pharmaceutical development and drug delivery, including scientific investigation specifically exploring the formulation and new technologies of TDDS products. He was a Visiting Scientist at Professor Robert Langer's laboratories in MIT from 1997 to 1999, and a Vice President at Noven Pharmaceuticals, a subsidiary of Hisamitsu from 2015 to 2017. He holds a Doctor of Pharmaceutical Sciences degree from Kyusyu University and both Master and Bachelor of Pharmaceutical Sciences degrees from Kumamoto University.